Hedia

About Hedia

Hedia is a digital therapeutics company focused on diabetes management. Their goal is to improve the quality of life for people with diabetes by providing innovative solutions for self-management and achieving better health outcomes.

Products & Services

Hedia Diabetes Assistant:A class IIb medical device designed to support the management of insulin-requiring diabetes. It helps patients achieve better health outcomes by stabilizing blood glucose levels and is available in multiple European countries through healthcare professionals.

Specialties

Diabetes Management Digital Therapeutics (DTx) Insulin Dosing Solutions Blood Glucose Monitoring

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Seed Extension T: - FT: Seed Extension	A: 3240000 MR: - FA: €3 million FAN: 3240000	D: 2024-02-27 FD: 2024-02-27	2 investors

Seed Extension Latest

2024-02-27

$3.2M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Lorna May Wadsworth

Artist

A

Anne Birk Østerskov

MD

LinkedIn (Pro only)

M

Maciej Stolarski

Head of Business Operations

LinkedIn (Pro only)

P

Pernille Rudebeck Mogensen

V

Valentin Lubbe

N

Niklas Karre-Gundlev

Chief Technology Officer

View 33 more team members with Pro

Unlock Full Team Directory

Recent News

Hedia Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised